OPENLAB VERIFIED
Report identity and source-transcribed quantity. Compound purity and analytical events retain their separate source scopes.
S-4ANDARINE
- Batch
- OL2287
- Report
- R41330
- Laboratory
- Janoshik Analytical
- Analysed
- 26 April 2024
Powered by EvidenceOS, connecting this Olympus Labs UK product and batch to its laboratory results and source evidence.
Hover to inspect · enlarge for scroll, pan and zoom
Six checks for this batch.
- Product
- S-4
- Batch
- OL2287
- Report
- R41330
- 01✓
- 02✓
- 03✓
- 04✓
- 05✓
Raw material to finished product
Follow the product from raw-material purity testing to the finished-product laboratory report. Each result describes a distinct stage.
- 01 · Raw-material sampleC-699
Pre-production purity assay
- 02 · Raw-material lotIdentifier not supplied
Used in the production batch
- 03 · Production batchOL2287
Finished capsules
- 04 · Finished-product testJanoshik R41330
Concentration and identification
Production linkage and source coverage
The product owner confirms that the pre-production raw material was used in this production batch, whose finished capsules were sampled for concentration and identification testing. Laboratory observations retain their own sample and event identities.
Confirmed by Product owner, 2026-09-07. External identifiers remain unfilled where they were not supplied.
- External raw-material lot identifier is not supplied.
Analytical results
- Report
- R41330
- Batch
- OL2287
- Recorded
- 26 April 2024
- Signal
- PDA Ch1 220–260 nm
OPENLAB / ANALYTICAL EVIDENCE
Concentration
Discrete quantity measurements from the selected analytical run.
View data table
| Peak | Retention time (min) | Quantity (mg) |
|---|---|---|
| 1 | 0.813 | 27.505 |
OPENLAB / ANALYTICAL EVIDENCE
Compound identity
The expected compound, observed identification and source conclusion stay together.
- Product
- S-4
- Compound
- Andarine
- Alias
- ANDARINE
- Report
- R41330
OPENLAB / ANALYTICAL EVIDENCE
Measured quantity
The source result, with its original unit and sample basis.
- Compound
- Andarine
- Sample
- Reported sample; the laboratory gives mg without a per-capsule denominator.
OPENLAB / ANALYTICAL EVIDENCE
Reported purity
The source result, with its original unit and sample basis.
- Compound
- Andarine
- Sample
- Compound raw material
Peak profile
- Analysis
- Compound reference
- Recorded
- 18 March 2024
- Signal
- DAD1 A, 214 nm
Earlier compound analysis · recorded separately from the 26 April 2024 batch report.
Sample C-699: 99.4172% main-peak area. Owner-associated raw-material assay, separate from Janoshik 41330. Laboratory identity is not printed.
OPENLAB / ANALYTICAL EVIDENCE
Reported peak profile
Area and signal height describe different properties of each reported peak.
View data table
| Peak | Retention (min) | Area (%) | Height (mAU) | Width (min) |
|---|---|---|---|---|
| 1 | 9.627 | 0.113 | 2.657 | 0.079 |
| 2 | 10.493 | 99.417 | 2,119.275 | 0.089 |
| 3 | 11.332 | 0.109 | 2.173 | 0.098 |
| 4 | 12.608 | 0.361 | 6.313 | 0.11 |
OPENLAB / ANALYTICAL EVIDENCE
S-4 · PDA Ch1 220–260 nm · 2024-04-26
Inspect the whole source image, then zoom into its recorded detail.
Fit · complete source image · Use zoom controls, then scroll inside the image to inspect detail.
OPENLAB / ANALYTICAL EVIDENCE
S-4 / C-699 · original HPLC page rendering
Inspect the whole source image, then zoom into its recorded detail.
Fit · complete source image · Use zoom controls, then scroll inside the image to inspect detail.
Analytical methods
Chromatography
- Signal
- PDA Ch1 220–260 nm
- Recorded
- 26 April 2024
HPLC
- Signal
- DAD1 A, 214 nm
- Recorded
- 18 March 2024
- Testing ordered
- 11 April 2024
- Sample received
- 23 April 2024
- Analysed
- 26 April 2024
Janoshik Analytical
- Report
- R41330
- Batch
- OL2287
Explore the available findings and source evidence for S-4.
S-4
- Batch
- OL2287
- Report
- R41330